Budget impact model of avelumab in patients with metastatic merkel cell carcinoma in the US

ανά Bharmal, Murtuza, Kearney, Mairead, Zheng, Ying, Phatak, Hemant
Τόπος έκδοσης Clinicoecon Outcomes Res (2019)

Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials

ανά Bharmal Murtuza, Bhanegaonkar Abhijeet, Canafax Daniel M, Calloway Michael
Έκδοση 2011-04-01

Validation of the post sleep questionnaire for assessing subjects with restless legs syndrome: results from two double-blind, multicenter, placebo-controlled clinical trials

ανά Canafax, Daniel M, Bhanegaonkar, Abhijeet, Bharmal, Murtuza, Calloway, Michael
Έκδοση 2011

What is the Impact of the Analysis Method Used for Health State Utility Values on QALYs in Oncology? A Simulation Study Comparing Progression-Based and Time-to-Death Approaches

ανά Hatswell, Anthony J., Bullement, Ash, Schlichting, Michael, Bharmal, Murtuza
Τόπος έκδοσης Appl Health Econ Health Policy (2020)

Trends in CNS Prescribing Following the Economic Slowdown

ανά Cascade, Elisa, Kalali, Amir H., Kwentus, Joseph A., Bharmal, Murtuza
Έκδοση 2009

Update on the psychometric properties and minimal important difference (MID) thresholds of the FACT-M questionnaire for use in treatment-naïve and previously treated patients with...

ανά Bharmal, Murtuza, Nolte, Sandra, Henry-Szatkowski, Mickaël, Hennessy, Meliessa, Schlichting, Michael
Τόπος έκδοσης Health Qual Life Outcomes (2020)

Evaluation of survival extrapolation in immuno-oncology using multiple pre-planned data cuts: learnings to aid in model selection

ανά Bullement, Ash, Willis, Anna, Amin, Amerah, Schlichting, Michael, Hatswell, Anthony James, Bharmal, Murtuza
Τόπος έκδοσης BMC Med Res Methodol (2020)

How to address the challenges of evaluating treatment benefits-risks in rare diseases? A convergent mixed methods approach applied within a Merkel cell carcinoma phase 2 clinical t...

ανά Bharmal, Murtuza, Guillemin, Isabelle, Marrel, Alexia, Arnould, Benoit, Lambert, Jérémy, Hennessy, Meliessa, Fofana, Fatoumata
Τόπος έκδοσης Orphanet J Rare Dis (2018)

Living with Merkel Cell Carcinoma (MCC): Development of a Conceptual Model of MCC Based on Patient Experiences

ανά Kaufman, Howard L., Dias Barbosa, Carla, Guillemin, Isabelle, Lambert, Jérémy, Mahnke, Lisa, Bharmal, Murtuza
Τόπος έκδοσης Patient (2018)

Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma

ανά Nghiem, Paul, Kaufman, Howard L, Bharmal, Murtuza, Mahnke, Lisa, Phatak, Hemant, Becker, Jürgen C
Τόπος έκδοσης Future Oncol (2017)

Survival Analysis in Patients with Metastatic Merkel Cell Carcinoma Treated with Avelumab

ανά Lanitis, Tereza, Proskorovsky, Irina, Ambavane, Apoorva, Hunger, Matthias, Zheng, Ying, Bharmal, Murtuza, Phatak, Hemant
Τόπος έκδοσης Adv Ther (2019)

Budget Impact Of Including Avelumab As A Second-Line Treatment For Locally Advanced Or Metastatic Urothelial Cancer In The United States: Commercial And Medicare Payer Perspectives

ανά Kongnakorn, Thitima, Bharmal, Murtuza, Kearney, Mairead, Phatak, Hemant, Benedict, Agnes, Bhanegaonkar, Abhijeet, Galsky, Matthew
Τόπος έκδοσης Clinicoecon Outcomes Res (2019)

Validation of an abbreviated Treatment Satisfaction Questionnaire for Medication (TSQM-9) among patients on antihypertensive medications

ανά Bharmal, Murtuza, Payne, Krista, Atkinson, Mark J, Desrosiers, Marie-Pierre, Morisky, Donald E, Gemmen, Eric
Έκδοση 2009

Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma

ανά Bharmal, Murtuza, Fofana, Fatoumata, Barbosa, Carla Dias, Williams, Paul, Mahnke, Lisa, Marrel, Alexia, Schlichting, Michael
Τόπος έκδοσης Health Qual Life Outcomes (2017)

Correction to: Psychometric properties of the FACT-M questionnaire in patients with Merkel cell carcinoma

ανά Bharmal, Murtuza, Fofana, Fatoumata, Barbosa, Carla Dias, Williams, Paul, Mahnke, Lisa, Marrel, Alexia, Schlichting, Michael
Τόπος έκδοσης Health Qual Life Outcomes (2019)

Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma

ανά Bullement, Ash, Nathan, Paul, Willis, Anna, Amin, Amerah, Lilley, Cameron, Stapelkamp, Ceilidh, Hatswell, Anthony, Pescott, Chris, Bharmal, Murtuza
Τόπος έκδοσης Pharmacoecon Open (2019)

Treatment Sequencing Patterns in Patients with Metastatic Urothelial Cancer Treated in the Community Practice Setting in the United States: SPEAR-Bladder (Study informing treatment...

ανά Doshi, Gurjyot K, Bhanegaonkar, Abhijeet, Kearney, Mairead, Bharmal, Murtuza, Cislo, Paul, Kim, Ruth, Boyd, Marley, Aguilar, Kathleen M, Phatak, Hemant
Τόπος έκδοσης Clinicoecon Outcomes Res (2020)

Patient Experiences with Avelumab in Treatment-Naïve Metastatic Merkel Cell Carcinoma: Longitudinal Qualitative Interview Findings from JAVELIN Merkel 200, a Registrational Clinica...

ανά Lambert, Jérémy, Marrel, Alexia, D’Angelo, Sandra P., Burgess, Melissa A., Chmielowski, Bartosz, Fazio, Nicola, Gambichler, Thilo, Grob, Jean-Jacques, Lebbé, Céleste, Robert, Caroline, Russell, Jeffrey, Güzel, Gülseren, Bharmal, Murtuza
Τόπος έκδοσης Patient (2020)

Evaluation of real-world treatment outcomes in patients with distant metastatic Merkel cell carcinoma following second-line chemotherapy in Europe

ανά Becker, Jürgen C., Lorenz, Eva, Ugurel, Selma, Eigentler, Thomas K., Kiecker, Felix, Pföhler, Claudia, Kellner, Ivonne, Meier, Friedegund, Kähler, Katharina, Mohr, Peter, Berking, Carola, Haas, Gabriele, Helwig, Christoph, Oksen, Dina, Schadendorf, Dirk, Mahnke, Lisa, Bharmal, Murtuza
Τόπος έκδοσης Oncotarget (2017)

Early objective response to avelumab treatment is associated with improved overall survival in patients with metastatic Merkel cell carcinoma

ανά D’Angelo, Sandra P., Hunger, Matthias, Brohl, Andrew S., Nghiem, Paul, Bhatia, Shailender, Hamid, Omid, Mehnert, Janice M., Terheyden, Patrick, Shih, Kent C., Brownell, Isaac, Lebbé, Céleste, Lewis, Karl D., Linette, Gerald P., Milella, Michele, Schlichting, Michael, Hennessy, Meliessa H., Bharmal, Murtuza
Τόπος έκδοσης Cancer Immunol Immunother (2019)